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Abstract. Epidemiologic studies conducted in the US have not previously detected an association between regional drink-
ing water arsenic concentrations and corresponding cancer occurrence or mortality rates.  To improve our estimation of
cancer risk and arsenic exposure in the USA, we have investigated the reliability of several exposure markers.  In the cur-
rent study, we specifically evaluated the long-term reproducibility of tap water and toenail concentrations of arsenic, and
the relation between water, toenail, and urinary measurement. Subjects included 99 controls in our case-control study on
whom we requested a household tap water sample and toenail clipping three to five years apart. Additionally, participants
were asked to provide a first morning void sample at the second interview. Tap water arsenic concentrations ranged from
undetectable (<0.01 µg/L) to 66.6 µg/L. We found a significant correlation between both replicate water and toenail sam-
ples (intraclass correlation coefficient = 0.85, 95% confidence interval = 0.79–0.89 for water, and intraclass correlation
coefficient = 0.60, 95% confidence interval = 0.48–0.70 for toenails). The inter-method correlations for water, urinary and
toenail arsenic were all statistically significant (r = 0.35, p = 0.0024 for urine vs water; r = 0.33, p = 0.0016 for toenail vs
water and r = 0.36, p=0.0012 for urine vs toenails). Thus, we found both toenail and water measurements of arsenic repro-
ducible over a three- to five-year period. Our data suggest that biologic markers may provide reliable estimates of internal
dose of low level arsenic exposure that can be used to assess cancer risk.
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INTRODUCTION
Arsenic is an established human carcinogen based on studies of
populations ingesting high levels of arsenic in their drinking
water [1,2]. But, it is unclear whether effects occur at the low
levels experienced in the USA. Studies of cancer endpoints
require long-term measures of exposure since the latency period
for clinically evident disease may be several years if not decades.
Also, because cancer is a rare event, studies, such as ours [3]
often use a case-control design.  A major advantage to using bio-
logic or environmental markers (versus patient recall) is that
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they are not subject to differential misclassification, resulting
from interviewer or recall biases inherent to case-control studies.
Blood levels of arsenic generally do not reflect long term
exposure since arsenic is cleared from the blood within a few
hours.  Urinary arsenic is a potential biologic marker of
arsenic exposure, but only may be a short-term measure since
arsenic is cleared from the body via the kidneys within a few
days [4]. Moreover, it is uncertain how well urinary arsenic
reflects intake in populations exposed to low levels of arsenic
in their drinking water, and whether the disease process itself
(i.e., bladder cancer) affects concentrations. Arsenic accumu-
lates in hair and nail tissue due to its affinity for sulfhydryl
groups in keratin [5,6]. We previously reported a significant
correlation between drinking water and toenail concentra-
tions among those whose drinking water contained 1 µg/L to
180 µg/L of arsenic in the New Hampshire population [7].  
To examine the long-term reproducibility of drinking
water and toenail measures of arsenic, we re-tested a sam-
ple of participants from our original study. We further
tested the inter-method correlations of drinking water,
toenail and urinary measures.
METHODS
We selected controls from our non-melanoma skin cancer
case-control study on whom we analyzed a toenail and water
sample three to five years ago [3]. We first sent a letter to
these subjects, summarizing the trace element results from
the original study and that we might re-contact them for the
biologic marker sub-study. The letter was followed by a tele-
phone call from an interviewer who arranged a time to meet
those who agreed to take part.  Prior to the interview, we sent
the instructions [8] and materials to collect toenail clippings.
Based on the findings of Calderon and colleagues, we asked
participants to collect a ”first morning” urine sample in the
morning of the interview, to place it in an insulated thermos
and to refrigerate it until the interviewer arrived. We provid-
ed participants with gloves and instructions for sample collec-
tion. The interviewer collected a tap water sample using 125
ml HDPE bottles (I-CHEM) following a previously described
protocol [3] and asked subjects whether they moved or
changed water supplies since they were originally tested. 
Laboratory methods
Toenail clipping samples were analyzed for arsenic and
other trace elements by the instrumental neutron activa-
tion analysis (INAA) at the University of Missouri
Research Reactor, using a standard comparison approach
as described previously [9,10]. Samples of sufficient
weight were split and run in replicate. If the coefficient of
variability (CV, mean divided by the standard deviation)
exceeded 15%, the batch was recounted to ensure that the
mass and signal were accurately measured and recorded.
The limit of detection for arsenic measured by INAA is
approximately 0.001 µg/g.
Samples of drinking water were analyzed for arsenic con-
centration using a Finnigan MAT Corp. ELEMENT high
resolution inductively coupled mass spectrometer (HR-
ICP-MS) equipped with a precision glass blowing corp.
VS-1 membrane gas liquid separator to allow hydride gen-
eration (HG) for enhanced sensitivity [11]. All sample
preparations and analyses were carried out in a trace-
metal clean HEPA-filtered-air environment. Analytical
blanks and potential instrumental drifts were carefully
monitored, and instrument standardization and repro-
ducibility were performed with Certified Standard
Reference Materials. The limit of detection, using HG-
HR-ICP-MS is 0.01 µg/L, two orders of magnitude lower
than conventional methods.
Analyses of arsenic speciation in urine samples were car-
ried out by using ion pair chromatographic separation with
hydride generation atomic fluorescence detection (HPLC-
HGAFD) [12]. A HPLC system consisted of a Gilson
(Middleton, WI) HPLC pump (Model 307), a Rheodyne
6-port  sample injector (Model 7725i) with a 20-µL sample
loop, and  a reversed phase C18 column (ODS-3, 150 • 4.6
mm) with 3 µm particle size packing materials
(Phenomenex, Torrance, CA).  The column was mounted
inside a column heater (Model CH-30, Eppendorf) which
was controlled by a temperature controller (Model TC-50,
Eppendorf). Column temperature was maintained at
50oC. A mobile phase solution (pH 5.9) contained 5 mM
tetrabutylammonium hydroxide, 3 mM malonic acid, and
5% methanol, and its flow rate was 1.2 mL/min. A hydride
generation atomic fluorescence detector (HGAFD)
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(Model Excalibur 10.003, P.S. Analytical, Kent, UK) was
used for the detection of arsenic. The combination of
HPLC and HGAFD has been described previously [13].
An aliquot (20 uL) of a urine sample was filtered through
a 0.45 µm membrane prior to be subjected to HPLC-
HGAFD analysis.  The limit of detection for each fraction
was 0.5 to 1.0 µg/L.  
Statistical Analysis
We linked current data on toenail, water and urine arsenic
with data obtained from the original interview (including
demographic data, toenail and water analysis). To assess
the reproducibility of the water and toenail samples over
a three- to five-year period, we used normal random effect
models to estimate the intra class correlation between
each of the repeated measures along with appropriate
confidence intervals.  The three water samples with unde-
tectable levels were set to 0.005 µg/L, one-half of the usual
detection limit, and the two subjects who moved were
excluded. We also computed the correlation between
measurements, water, urine and toenail concentrations in
our population measured at the second interview. In this
analysis, we excluded individuals with undetectable uri-
nary or tap water arsenic. We summed over urinary frac-
tions to obtain total urine concentration.  We carefully
examined scatter plots for linearity and normality and
chose a natural log transformation on this basis. 
RESULTS
We enlisted 99 controls previously interviewed in the bio-
logic marker reliability study. The mean interval between
the original and second interview was 3.8 years (SD = 0.35
years).  Forty-four percent were women and 56% were
men with overall mean age of 66.9 years (SD = 10.8). Of
these subjects, 96 provided a toenail clipping sample, 92 a
urine sample and 98 a water sample.
Concentrations of toenail, water and total urinary arsenic
are shown in Table 1. We found detectable levels of
arsenic in all toenail, and all but three water samples.
Concentration in water ranged from undetectable (<0.01
µg/L) to 54.1 µg/L and in toenails varied from 0.02 to 0.53
µg/g.  Seventy-seven out of 91 subjects (84.6%) had at
least one detectable fraction of urinary arsenic. 
n Mean (SD) n Mean (SD)
Toenail µg/g 99 0.13  (0.10) 96 0.11 (0.08)
Water µg/L 99 3.51  (9.86) 96 2.72  (8.06)
Urine µg/L – – 77 9.89   (14.50)
Original Interview Second Interview
Table 1. Values of toenail, water and urine levels of arsenic in samples
collected during the original and second interviews
Fig. 1.  Water arsenic concentrations at the first and second interviews,
Intraclass correlation 0.85 (95% CI: 0.79–0.89).
Fig. 2. Toenail arsenic concentrations at the first and second inter-
views. Intraclass correlation 0.60 (95% CI: 0.48–0.70).
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We found a strong correlation between the original and
subsequent tap water concentrations (intraclass correla-
tion coefficient = 0.85, 95% CI: 0.79 - 0.89) (Fig. 1).
Likewise, we found a significant correlation between the
replicate toenail measurements (intraclass correlation
coefficient = 0.60, 95% CI: 0.48 - 0.70) (Fig. 2). 
In our data, both toenail and urine concentrations correla-
ted with water concentrations, particularly among those
with water arsenic greater than or equal to 1 µg/L (r =
0.46, p = 0.029 for urine vs water; r= 0.64, p = 0.006 for
toenail vs water) (Table 2).  Toenail and urine concentra-
tions also correlated with each other (r = 0.36, p = 0.0012
for urine vs toenails) (Table 2).
DISCUSSION
To our knowledge, our study is among the first to evaluate
the reliability of various measurements of arsenic expos-
ure in population exposed to low, however potentially car-
cinogenic, levels of arsenic. 
In regions with relatively high drinking water concentra-
tions, urinary arsenic generally correlates with water levels
[8,14,15]. In a study of two Chilean towns, inorganic
arsenic and the methylated metabolites were strongly cor-
related with drinking water concentrations in the two
towns combined, but correlations within each town were
lower [14]. In the town with elevated drinking water
arsenic concentrations (up to 670 µg/L), the overall correla-
tion between water and urine levels was 0.26 (p < 0.003,
and in the other town, with lower levels (15 µg/L), it was
0.25 (p < 0.009). An important limitation of our study was
that a number of subjects had undetectable levels of uri-
nary arsenic (levels below 0.5 or 1.0 µg/L).  We also were
unable to examine the reproducibility of urine concentra-
tions over time because we only collected urine samples at
the second interview. Nonetheless, our results are consist-
ent with the Chilean study, and suggest that other sources
of exposure (e.g., diet) may contribute to urinary arsenic
levels in populations with low drinking water levels. 
Both hair and nails have been used forensically to track
arsenic poisoning over a period of several months [5,6].
Airborne, water and food exposure to arsenic each have
been related to nail concentrations [1,2]. Nails are gener-
ally considered less susceptible to external contamination
than hair. They are easy to collect and can be analyzed for
an array of trace elements (e.g., selenium, mercury, zinc).
In a study of female nurses tested 6 years apart, toenail
arsenic concentrations were most highly correlated among
the trace elements studied (r = 0.54), suggesting that
these measurements reflect exposures over even longer
periods [16]. Our data confirm the long-term repro-
ducibility of toenail measures in populations exposed to
low levels of arsenic through the drinking water supply.
Exposure assessment based on drinking water samples is an
alternative approach to the use of a biomarker, particular-
ly if there is minimal exposure from other sources (i.e.,
diet or occupational activities). But, the extent to which
water concentrations vary over time is not well-character-
ized.  Cebrian and colleagues collected 18 to 20 water
samples between 1975 in two Mexican towns, one with a
mean concentration of 411 µg/L and another with a mean
concentration of 5 µg/L [17]. In the high-exposure town,
values varied considerably from 160 µg/L to 590 µg/L (SD
= 0.114 µg/L). In the low exposure town, values appeared
more stable (SD = 0.007 µg/L). Recently, a study con-
ducted in Maryland, USA found significant variation in
water samples taken every two months for one year [18].
Thus, fluctuations in water concentrations may depend on
Water Arsenic< 1 µg/L Water Arsenic> µg/L Overall
correlation (p-value) correlation (p-value) correlation (p-value)
Urine vs Water .  0.02     (p = 0.90) 0.46    (p = 0.029) 0.35    (p = 0.0024)
Toenail vs Water -0.19    (p = 0.13) 0.64    (p = 0.006) 0.33    (p = 0.0016)
Urine vs Toenail 0.25    (p = 0.071) 0.42    (p = 0.044) 0.36    (p = 0.0012)
Table 2. Correlations between tap water, urine and toenail arsenic concentrations from the second interview
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the water supply and its geochemical characteristics. In
our study of New Hampshire drinking water supplies, lev-
els of arsenic remained surprisingly consistent.  Moreover,
in our previous analysis of 217 households, we found no
seasonal pattern in water arsenic levels [7].
In summary, we found that both drinking water and toe-
nail measurements of arsenic remained fairly consistent
over a three- to five-year period. In our population, toe-
nail, water and urinary arsenic concentrations were each
significantly correlated. But, our results indicated that fac-
tors other than drinking water may be contributing to
urine and toenail concentrations.  Use of biologic markers
may more accurately reflect total dose of exposure in popu-
lations exposed to low, but potentially carcinogenic levels
of drinking water arsenic.
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